Search
for
Sort by
Research 691–720 of 1000+
- Dacomitinib-Induced Paronychia Associated With PRIDE Syndrome in a Patient With Non-Small Cell Lung Cancer
- Steroid Sulfatase in the Human Hair Follicle Concentrates in the Dermal Papilla
- Diagnosis and treatments of hirsutism: where are we?
- Drugs and Androgenetic Alopecia: What to look out for
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- The JAK/STAT signaling pathway: from bench to clinic
- 5alpha-reductase: history and clinical importance.
- Idiopathic Hirsutism*
- Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence
- Comprehensive clinical management of hirsutism
- Perspectives on miRNAs Targeting DKK1 for Developing Hair Regeneration Therapy
- Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management
- Cost-effective therapy in patients with idiopathic hirsutism
- Pharmacological Treatment of Alopecia
- Tofacitinib in alopecia areata and HIV: A curious intersection of immunomodulation, hair regrowth, and hypertrichosis
- New Drugs for Alopecias
- 440 Topical application of anti-cancer drug Bortezomib stimulates proliferation of follicular cells and induces expression of hair keratins via GATA-3 transcription factor
- PRIDE syndrome with lumbosacral hypertrichosis
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Alopecia areata
- Bone morphogenetic protein signaling regulates the size of hair follicles and modulates the expression of cell cycle-associated genes
- Management of congenital ichthyoses: European guidelines of care, part two
- Clinical biochemistry of dihydrotestosterone
- Epidermal expression of the truncated prelamin A causing Hutchinson-Gilford progeria syndrome: effects on keratinocytes, hair and skin
- Birt–Hogg–Dubé syndrome: from gene discovery to molecularly targeted therapies
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Molecular Genetics of the PI3K-AKT-mTOR Pathway in Genodermatoses: Diagnostic Implications and Treatment Opportunities
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Cetuximab-Associated Elongation of the Eyelashes
- Immune cell regulation of the hair cycle